Historical record - last NADAC publication: 1/22/2020

Product Information

ZORTRESS 0.5 MG TABLET is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $17.8041 per EA under NDC 00078041420. Its NADAC has been published 344 times since Jun 18, 2014.

The High Outlier badge above means this manufacturer's average price in the everolimus market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

ZORTRESS 0.5 MG TABLET

everolimus
$17.8041per EA
High Outlier

Strength

.5 mg/1

NDC

00078041420

Classification

Brand

Dosage Form

TABLET

Route

ORAL

Last Updated

1/22/2020

Active Ingredients

EVEROLIMUS

Approval Type

New Drug (NDA)

FDA Application

NDA021560

On Market Since

4/22/2010

Pharmacological Classes

Cytochrome P450 2D6 Inhibitors
Cytochrome P450 3A4 Inhibitors
Decreased Immunologic Activity
Kinase Inhibitor
Protein Kinase Inhibitors
mTOR Inhibitor Immunosuppressant
mTOR Inhibitors

Price Statistics

The NADAC for ZORTRESS 0.5 MG TABLET has been published 344 times since Jun 18, 2014, and over the history we have for it it has risen 39.3%. The table below summarizes its recorded NADAC range and movement.

Current price$17.8041 per EA
All-time high$17.8730 (Jan 15, 2020)
All-time low$12.7813 (Jun 18, 2014)
Median price$15.8542
Average price$15.5752
Largest weekly change+7.0% (Jul 15, 2015)
Weeks tracked344
Tracking sinceJun 18, 2014

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

+39.3%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the everolimus market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of ZORTRESS 0.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ZORTRESS 0.5 MG TABLET, manufactured by Novartis Pharmaceuticals Corporation, is $17.8041 per EA (NDC 00078041420), effective Jan 13, 2021.

How has the price of ZORTRESS 0.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for ZORTRESS 0.5 MG TABLET has risen 39.3%. It has been tracked across 344 weekly CMS publications since Jun 18, 2014.

What are the highest and lowest recorded NADAC prices for ZORTRESS 0.5 MG TABLET?

Since Jun 18, 2014, the NADAC for ZORTRESS 0.5 MG TABLET has ranged from a low of $12.7813 (Jun 18, 2014) to a high of $17.8730 (Jan 15, 2020), with a median of $15.8542 per EA.

Are there cheaper alternatives to ZORTRESS 0.5 MG TABLET?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ZORTRESS 0.5 MG TABLET, so no direct lower-cost alternative is listed.

Who manufactures ZORTRESS 0.5 MG TABLET?

ZORTRESS 0.5 MG TABLET (NDC 00078041420) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.